 MINNEAPOLIS, MN ACCESSWIRE May 26, 2022 Celcuity Inc. NASDAQ:CELC, a clinical-stage biotechnology company pursuing an integrated therapeutic and companion diagnostic strategy for treating patients with cancer, today announced that Brian Sullivan, Chairman, Chief Executive Officer, and Co-founder of Celcuity, will participate in the following investor conferences: One-on-one and small group meetings at the 19th Annual Craig-Hallum Institutional Investor Conference virtual on Wednesday, June 1, 2022; and A fireside chat at the Jefferies Healthcare Conference in New York at 2:30 p.m. ET on Thursday, June 9, 2022. 